A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia

Local Institution, St Leonards

Local Institution, Parkville

Local Institution, Adelaide

Local Institution, Orbassano

Campus Virchow Klinikum Der Charite, Berlin

Local Institution, Madrid

Winship Cancer Institute, Atlanta

Local Institution, Bordeaux

Local Institution, Valencia

Universitaetsklinikum Bonn, Bonn

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

Universitaetsklinik Frankfurt, Frankfurt am Main

Ut Southwestern Medical Center At Dallas, Dallas

The University Of Texas MD Anderson Cancer Center, Houston

Local Institution, Napoli

Dana Farber Cancer Institute., Boston

QEII Health Sciences Centre-VG Site, Halifax

Princess Margaret Cancer Centre, Toronto

Hopital Maisonneuve-Rosemont, Montreal

Universitaetsklinikum Carl Gustav Carus, Dresden

Local Institution, Roma